Results 11 to 20 of about 951,374 (223)

Yellow Fever Virus Vaccine–associated Deaths in Young Women

open access: yesEmerging Infectious Diseases, 2011
Yellow fever vaccine–associated viscerotropic disease is a rare sequela of live-attenuated virus vaccine. Elderly persons and persons who have had thymectomies have increased susceptibility.
Stephen J. Seligman
doaj   +2 more sources

An Atypical Local Vesicular Reaction to the Yellow Fever Vaccine

open access: yesVaccines, 2017
Yellow fever vaccine is a live attenuated viral inoculation indicated for patients traveling to endemic areas. The vaccine is generally well tolerated with minimal adverse effects.
Robert H. Wauters   +2 more
doaj   +2 more sources

Antibody response to 17D yellow fever vaccine in Ghanaian infants

open access: yesBulletin of the World Health Organization, 2001
OBJECTIVE: To assess the seroresponses to yellow fever vaccination at 6 and 9 months of age; assess any possible adverse effects of immunization with the 17D yellow fever vaccine in infants, particularly at 6 months of age.
Osei-Kwasi Mubarak   +5 more
doaj   +1 more source

Basal T cell activation predicts yellow fever vaccine response independently of cytomegalovirus infection and sex-related immune variations. [PDF]

open access: yesCell Rep Med
International audienceThe live-attenuated yellow fever 17D (YF17D) vaccine is a model of acute viral infection that induces long-lasting protective immunity. Among immunocompetent adults, responses to YF17D vary significantly.
Santos-Peral A   +22 more
europepmc   +2 more sources

Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report

open access: yesBMC Infectious Diseases, 2020
Background Yellow fever vaccine exists for over 80 years and is considered to be relatively safe. However, in rare cases it can produce serious neurotropic and viscerotropic complications.
Lev Volkov   +10 more
doaj   +1 more source

Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

open access: yesMolecular Therapy: Methods & Clinical Development, 2022
New platforms are needed for the design of novel prophylactic vaccines and advanced immune therapies. Live-attenuated yellow fever vaccine YF17D serves as a vector for several licensed vaccines and platform for novel candidates. On the basis of YF17D, we
Li-Hsin Li   +12 more
doaj   +1 more source

Malaria transmission in Africa: Its relationship with yellow fever and measles.

open access: yesPLoS ONE, 2022
BackgroundMalaria has been strongly linked to the transmission and pathophysiology of some viral diseases. Malaria and vaccine-preventable diseases often co-exist in endemic countries but the implication of their co-existence on their transmission ...
Oluyemi A Okunlola, Oyetunde T Oyeyemi
doaj   +1 more source

The use of a computerized database to monitor vaccine safety in Viet Nam. [PDF]

open access: yes, 2005
Health information systems to monitor vaccine safety are used in industrialized countries to detect adverse medical events related to vaccinations or to prove the safety of vaccines. There are no such information systems in the developing world, but they
Ali, Mohammad   +9 more
core   +4 more sources

Serious adverse event: late neurotropic disease associated with yellow fever vaccine

open access: yesEinstein (São Paulo), 2020
The yellow fever is a systemic disease that was under control due to the effective campaigns against the vector and promotion of vaccines programs. However, since 1999, outbreaks appeared because of inefficient control of the vector, and led to the need ...
Henrique Souza Barros de Oliveira   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy